Session objectives:
- Comprehend E6(R3) Guideline Revisions: key updates in E6(R3) and their significance for enhancing clinical trial practices and aligning with international standards.
- Analyze Regulatory Preparations: how different regulatory authorities are preparing for the implementation of E6(R3).
- Explore Data Integration: Consider the impact of E6(R3) on the use of Real-World Data (RWD) and Real-World Evidence (RWE), including the associated challenges and opportunities.
